HKEX: 2269 - WuXi Biologics (Cayman) Inc.

Yield per half year: +56.83%
Sector: Healthcare

Reporting WuXi Biologics (Cayman) Inc.

Reports

IFRS
Reporting Annual Quarterly
2017 2018 2019 2020 2021 2022 2023
Финансовый отчет link link link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд ¥
149.94 276.88 304.32 561.46 473.05 260.64 200.95 169.22
Выручка, млрд ¥
0.557 0.989 1.62 2.53 3.98 5.61 10.29 13.48 17.03 17.03
Чистая прибыль, млрд ¥
0.0445 0.1411 0.2526 0.6306 1.01 1.69 3.39 3.9 3.4 3.4
EV, млрд ¥
58.61 300.05 556.97 466.81 281 164.61
EBIT, млрд ¥
0.0509 0.0599 0.2272 0.4366 0.6941 1.06 1.76 4.03
EBITDA, млрд ¥
0.0523 0.0617 0.2281 0.5594 0.8379 1.28 2.06 4.93 5.49 6.22
Баланс стоимость, млрд ¥
0.146 0.2705 4.02 7.99 12.78 20.56 32.28 35.05 40.33 40.33
FCF, млрд ¥
-0.2272 -0.347 -0.3274 -1.07 -2.03 -4.14 -3.09 -0.3267 0.4372 0.4372
Операционный денежный поток, млрд ¥
0.1072 0.0819 0.3603 0.7616 1.21 1.88 3.43 5.54 4.67 4.67
Операционная прибыль, млрд ¥
0.0599 0.2272 0.4366 0.6941 1.06 1.76 4.03 4.79 4.45 4.45
Операционные расходы, млрд ¥
0.1208 0.1619 0.2239 0.3236 0.6018 3.85 6.83 9.24 12.58 12.58
CAPEX, млрд ¥
0.3344 0.4289 0.6877 1.83 3.23 6.02 6.51 5.87 4.23 4.23


Balance sheet

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд ¥
0.1582 0.1691 0.5039 4.08 6.21 7.1 9 6.4 9.67 9.67
Short Term Investments ¥
0.0333 1.56 0.543 1.38 2.12 2.32 1.57 1.57
Long term investments ¥
0.1923 0.4522
Total Receivables ¥
0.1903 0.3765 0.4928 0.9953 1.67 2.77 3.12 4.65 5.65 5.65
Total Current Assets ¥
0.6011 0.8299 3.03 5.75 9.67 14.2 19.53 18.47 21.2 21.2
Чистые активы, млрд ¥
0.754 1.15 1.78 2.9 6.8 12.87 19.76 25.92 18.47 25.92
Активы, млрд ¥
1.36 1.98 4.85 9.39 17.6 28.96 44.03 49.56 56.58 56.58
Short Term Debt ¥
0.0554 0.4559 0.1834 1.56 0.543 0.7671 2.12 0.5763 0.5763
Long Term Debt ¥
0.866 1.4 1.84 0.6405 2.95 1.57 1.57
Задолженность, млрд ¥
1.21 1.71 0.8246 1.4 4.71 8.06 11.75 14.52 12.56 12.56
Чистый долг, млрд ¥
0.0495 0.2976 0.9603 -0.5039 -4.08 -4.27 -4.49 -4.81 -7.52
Долг, млрд ¥
1.05 1.94 2.6 2.76 4.4 2.15 4.42
Interest income ¥
0.0025 0.0242 0.0357 0.0784 0.0227 0.0401 0.0392 0.0644 0.2192
Расходы на обслуживание долга ¥
0.0018 0.0834 0.0968 0.0196 0.0427 0.0392 0.7398 0.1585 0.1585
Чист. проц. доходы, млрд ¥
-0.0237 -0.0269 0.0784 0.0443 0.0381 0.0188 0.0431 0.0607 0.2402
Goodwill ¥
0.1854 0.1854 1.53 1.53 1.53
Амортизация, млрд ¥
0.0013 0.0018 0.000895 0.1227 0.1438 0.2214 0.303
Себестоимость, млрд ¥
0.3763 0.5999 0.9583 1.52 2.32 3.08 5.46 7.54 10.21 10.21
Товарно материальные запасы ¥
0.0499 0.079 0.1355 0.2272 0.3994 1.08 1.69 2.28 1.77 1.77


Share

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS 0.0724 0.1953 0.2911 0.4914 0.36 0.9237 0.7985 0.7985
Цена акции ао 43.7 50.15 98.65 102.8 92.55 59.85 29.6 17.6 17 17
Число акций ао, млн 3402.35 3481.07 3941.61 3997.13 3883.58 4084.76 4224.38 4225.26 4257.5 4257.5
FCF/акцию -0.0668 -0.0997 -0.0831 -0.2674 -0.5218 -1.01 -0.7319 -0.0773 0.1027 0.1027


Efficiency

IFRS
Reporting Annual Quarterly
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 30.49 52.17 6.28 7.89 7.93 8.21 10.5 11.59 9.02 9.02 8.15
ROA, % 3.28 7.11 5.21 6.71 5.76 5.83 7.7 8.34 6.41 6.41 5.11
ROS, % 15.61 24.88 25.45 30.09 32.93 28.95 19.96 19.96 19.96 19.96 7.36
ROCE, % 13.69 41.01 84.01 10.85 8.68 8.2 8.43 12.49 5.48
Рентаб EBITDA, % 15.75 11.08 23.07 34.55 33.06 32.09 36.79 39.19 40.76 40.76 6.06
Чистая рентаб, % 7.99 14.27 15.61 24.88 25.45 30.09 32.93 28.95 19.96 19.96 7.37
Operation Margin, % 26.97 27.39 26.53 31.39 39.19 35.51 26.12 26.12 26.12 26.12 9.85
Доходность FCF, % -0.2184 -0.386 -0.6659 -0.738 -0.6536 -0.1254 0.2176


Coefficients

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
593.52 439.08 300.18 332.45 139.6 52.19 30.83 30.83 22.50
P/BV
37.26 34.64 23.8 27.3 14.66 5.81 2.38 2.38 2.99
P/S
92.62 109.25 76.39 100.04 45.97 15.11 6.15 6.15 9.92
P/FCF
-457.9 -259.04 -150.16 -135.5 -153 -797.76 459.64 387.06 387.06 387.06 6.18
E/P
0.0017 0.0023 0.0033 0.003 0.0072 0.017 0.0169 0.0201 0.0201 0.0201 0.04
EV/EBITDA
74.37 61.42 234.71 269.78 57.28 26.45 -5.04
EV/Ebit
107.72 198.48 0 0 0
EV/S
75.32 99.24 45.36 10.78 9.66 9.66 9.66 46.67
EV/FCF
-148.06 -134.42 -150.98 376.51 376.51 376.51 16.02
Debt/EBITDA
4.6 1.52 1.26 0.7106 0.7106 0.7106 0.7106 0.72
Netdebt/Ebitda
4.82 4.21 -0.9008 -4.87 -3.34 -2.18 0 0 0 0 -0.64
Debt/Ratio
0.5287 0.1101 0.0899 0.0627 0.038 0.0781 0.0781 0.0781 0.10
Debt/Equity
3.88 0.1516 0.1267 0.0856 0.0532 0.1705 0.1705 0.1705 0.96
Debt/Net Income
7.44 1.91 1.54 0.8152 0.6316 1.3 1.3 1.3 1.14
Бета
1.09 3.3 4.47 3.38 3.38 1.48
Индекс Альтмана
35.77 35.6 20.34 22.05 6.48 4.59 4.05 4.05 4.05 5.87


Dividends

IFRS
Reporting Annual Quarterly
2015 2017 2018 2019 2020 2021 2022 2023 LTM Industry average 5 year average CAGR 5
Див.выплата, млрд
0.0181
Дивиденд
0
Див доход, ао, %
0 0 0 0 0 0 0 0 2.64
Дивиденды / прибыль, %
40.57 0 0 18.57


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 CAGR 5
Всего задолженность
1.32 2.87 4.5
ebit_margin
26.53 31.39 39.19
Персонал, чел
10593 12373 12740